Brett Gourley is an Oncology physician affiliated with MultiCare Health System. OpenAlex indexes 7 publications with 478 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
910 W 5th Ave Ste 700
Spokane, WA 992042967
Telephone
509-838-2531Registry record last updated 2 Jun 2014.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
- Celgene CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
30.9%Opioid Agonist10.1%Oxycodone Hcl61%Fentanyl15%Morphine Sulfate Er15%Hydromorphone Hcl10%Part D<11 patientsPhenothiazine7.7%Prochlorperazine Maleate100%Part D≥53 patients+ 7 more classes in this area
Cancer & immunology
24.4%Aromatase Inhibitor7.3%Letrozole75%Anastrozole13%Exemestane13%Part D<11 patientsKinase inhibitor5.2%Brukinsa49%Jakafi30%Ibrance21%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
18.3%Serotonin-3 Receptor Antagonist6.7%Ondansetron Odt69%Ondansetron Hcl31%Part D≥44 patientsCorticosteroid5.3%Prednisone100%Part D≥26 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Systemic coagulation is activated in patients with meningioma and glioblastoma
Journal of Neuro-Oncology
2021 - Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab
Cancer Chemotherapy and Pharmacology
2010
Similar KOLs
Other experts from the same institution or the same specialty.
Sarah Kranick, MD
MultiCare Health System
Mary Fairchok, MD
MultiCare Health System
Ravi Hira, MD
MultiCare Health System
Gad Kletter, MD
MultiCare Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”